• to decreased the potential risk of serious cardiovascular (coronary heart and blood vessel) complications in Grownups with sort 2 diabetes and cardiovascular diseaseThis led Novo Nordisk to conduct more analysis into higher dosages of semaglutide especially for weight administration.“There are several oral and injectable possibilities given t